Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
Filing tables
Filing exhibits
ENLV similar filings
Filing view
External links
Exhibit 15.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statement on Form F-3 (Registration No. 333-206032) and Registration Statements on Form S-8 (Registration No. 333-203114 and 333-210459) of Bioblast Pharma Ltd. of our report dated February 24, 2017 with respect to the consolidated financial statements of Bioblast Pharma Ltd. included in this Annual Report on Form 20-F of Bioblast Pharma Ltd. for the year ended December 31, 2016 filed with the Securities and Exchange Commission.
Tel-Aviv, Israel February 24, 2017 | /s/ Kost Forer Gabbay & Kasierer Kost Forer Gabbay & Kasierer A member of EY Global |